[Informe de investigación] Se espera que el tamaño del mercado de administración de medicamentos crezca de 20.99.856,7 millones de dólares en 2022 a 32.54.594,2 millones de dólares en 2028; se estima que registrará una tasa compuesta anual del 7,7 % entre 2023 y 2028.
El mercado de entrega de medicamentos está segmentado según la ruta de administración, el canal de distribución y el usuario final. y geografía. El informe ofrece información y análisis de mercado en profundidad, enfatizando parámetros como impulsores, tendencias, oportunidades y análisis del panorama competitivo de los principales actores del mercado en varias regiones. También incluye análisis del impacto de la pandemia de COVID-19 en las principales regiones.
Perspectivas del mercado
La creciente demanda de sistemas de administración de medicamentos no invasivos impulsa el mercado de administración de medicamentos
La administración de medicamentos no invasivos generalmente se refiere a métodos de administración de medicamentos indoloros en todo el sistema biológico. barreras de las superficies mucosas o de la piel. Este método de administración de medicamentos podría conducir a un mejor acceso a los medicamentos, la adherencia a los regímenes de tratamiento y mejores perfiles de seguridad de los medicamentos. Los pacientes prefieren vías de administración de fármacos no invasivas debido a las aparentes ventajas sobre la administración de fármacos mediante inyección. Se ha descubierto que el cumplimiento del paciente es mucho mayor cuando los medicamentos se administran mediante métodos no invasivos, ya que experimentan una disminución del dolor durante el procedimiento. Con mejoras en los dispositivos médicos y las tecnologías de administración transdérmica, el modo no invasivo de administración de medicamentos ahora está listo para competir con los métodos tradicionales de administración de medicamentos orales e inyectables. Algunos de los métodos populares de administración de fármacos no invasivos son: tópico, transdérmico activo (penetración mejorada asistida por un dispositivo), transdérmico pasivo, membrana transocular, membrana transmucosa y administración a través de una membrana alveolar a partir de medicamentos inhalados.
Una baja tasa de rechazo, facilidad de administración, conveniencia y durabilidad hacen del TDDS el método más atractivo de administración de medicamentos. Además de la administración farmacéutica en instalaciones médicas, TDDS podría usarse en diferentes procedimientos en la industria del cuidado de la piel. Dado que este método implica principalmente la administración local, puede prevenir la administración inespecífica a tejidos a los que no se dirige el fármaco. Es probable que los avances en TDDS ayuden a controlar la prevalencia de trastornos cardiovasculares y del sistema nervioso central, trastornos genéticos, diabetes, trastornos neuromusculares y enfermedades infecciosas (incluidas afecciones localizadas), al tiempo que impulsan avances en la vacunación y la preferencia de los pacientes por la autoadministración de medicamentos para tratamiento a largo plazo.
La administración de medicamentos a través de métodos no invasivos implica una frecuencia de dosificación reducida y esquemas de dosificación simplificados. Además, estos sistemas de administración pueden reducir significativamente el costo del uso clínico, ya que los pacientes pueden autoadministrarse medicamentos a través de estos métodos. En muchos casos, el costo de fabricación de medicamentos con sistemas de administración no invasivos es menor que los costos de producción de las inyecciones. Por ejemplo, la insulina inhalada se ha convertido en una modalidad preferida y bien tolerada para tratar la diabetes. Por lo tanto, la creciente demanda de sistemas de administración de medicamentos no invasivos impulsa el crecimiento del mercado de administración de medicamentos.
Perspectivas estratégicas
Información basada en la ruta de administración
Según la ruta de administración, el mercado de administración de medicamentos se segmenta en administración de medicamentos orales , administración de fármacos inyectables, administración de fármacos transmucosa, administración de fármacos tópicos, administración de fármacos implantables y administración de fármacos ocular. En 2022, el segmento de administración de medicamentos inyectables tenía la mayor participación del mercado de administración de medicamentos. Sin embargo, se prevé que el segmento de administración de medicamentos tópicos registre la CAGR más alta durante el período de pronóstico. La administración de medicamentos inyectables se considera una de las vías efectivas de administración de medicamentos debido a la velocidad y efectividad de la administración en el sitio objetivo y a la mejora de la experiencia del paciente. Las inyecciones ayudan a administrar medicamentos, vacunas o cualquier otro agente terapéutico en el cuerpo. La técnica de administración del fármaco por una vía distinta al tracto digestivo se denomina parenteral. La vía de administración parenteral incluye intramuscular, subcutánea e intravenosa. El desarrollo de inyectores sin agujas ha mejorado la administración de medicamentos de insulina al reducir el riesgo de lesiones por pinchazos en pacientes diabéticos.
Aumento del uso de inyecciones en procedimientos complejos de administración de medicamentos debido a los avances en Los sistemas de administración de medicamentos inyectables y la introducción de dispositivos inyectables de próxima generación con capacidades funcionales superiores mejoran el crecimiento del mercado global de administración de medicamentos para el segmento de administración de medicamentos inyectables.
Canal de distribución -Información basada en
Según el canal de distribución, el mercado de entrega de medicamentos se segmenta en farmacias hospitalarias, farmacias minoristas y farmacias en línea. El segmento de farmacias hospitalarias tuvo la mayor participación de mercado en 2022 y se espera que registre la CAGR más alta durante el período de pronóstico.
Mercado de entrega de medicamentos, por ruta de Administración– 2022-2028
Información basada en el usuario final
Según el usuario final, el mercado de entrega de medicamentos se segmenta en hospitales y clínicas, entornos de atención domiciliaria y otros usuarios finales. El segmento de hospitales y clínicas representó la mayor participación de mercado en 2022 y se proyecta que registre la CAGR más alta durante el período de pronóstico.
Los actores del mercado de administración de medicamentos adoptan estrategias orgánicas como lanzamiento y expansión de productos para ampliar su presencia geográfica y carteras de productos y satisfacer las crecientes demandas. Las estrategias de crecimiento inorgánico adoptadas por los actores del mercado les permiten expandir sus negocios y mejorar su presencia geográfica. Además, estas estrategias de crecimiento ayudan a las empresas a fortalecer su clientela y ampliar sus carteras de productos.
- En septiembre de 2022, Becton, Dickinson, and Company presentó una jeringa precargable de vidrio (PFS) de próxima generación y estableció un nuevo estándar en rendimiento para vacunas PFS con especificaciones nuevas y más estrictas en cuanto a procesabilidad, cosmética, contaminación e integridad. La nueva jeringa precargable de vidrio BD Effivax ha sido diseñada en colaboración con empresas farmacéuticas líderes para satisfacer las necesidades complejas y cambiantes de la fabricación de vacunas.
- En junio de 2022, Pfizer Inc. fortalecerá su compromiso con Fabricación en Estados Unidos con una inversión de 120 millones de dólares en sus instalaciones de Kalamazoo, Michigan, lo que permite la producción en Estados Unidos en apoyo de su tratamiento oral para COVID-19, PAXLOVID (tabletas de nirmatrelvir y tabletas de ritonavir). La inversión amplió la producción de ingredientes farmacéuticos activos (API) y materiales de partida registrados (RSM) utilizados para fabricar nirmatrelvir.
Perfiles de la empresa
- Becton Dickinson and Co
- Novo Nordisk AS
- Johnson & Johnson
- Boston Scientific Corp
- Pfizer Inc.
- Baxter International Inc
- Gerresheimer AG ;
- Kindeva Drug Delivery LP
- GlaxoSmithKline Plc
- Bausch Health Companies
- Novartis AG ;
- Sever Pharma Solutions
- Boehringer Ingelheim International
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The drug delivery market is analyzed in the basis of route of administration, distribution channel, and end user. Based on route of administration, is segmented into oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest market share in 2022. However, topical drug delivery segment is anticipated to register the highest CAGR during the forecast period.
The drug delivery market majorly consists of the players such as Pfizer Inc, Johnson & Johnson, Becton Dickinson and Co, Novo Nordisk AS, Boston Scientific Corp, Baxter International Inc, Gerresheimer AG, Kindeva Drug Delivery LP, GlaxoSmithKline Plc, Bausch Health Companies, Novartis AG, Sever Pharma Solutions, Boehringer Ingelheim International.
Drug delivery are various methodologies used to inject drugs or chemicals into the body. Some of the drug delivery available in the market include, transmucosal, oral, injectable, topical, implantable, and ocular among others. Drug delivery are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.
The factors that are driving the growth of market are growth are rising incidence of chronic diseases, growing demand for noninvasive drug delivery systems, and increasing R&D expenditures in pharmaceutical companies propel the market growth.
The List of Companies - Drug Delivery Market
- Becton, Dickinson and Co
- Novo Nordisk AS
- Boston Scientific Corp
- Baxter International Inc
- Gerresheimer AG
- Kindeva Drug Delivery LP
- GlaxoSmithKline Plc
- Bausch Health Companies
- Novartis AG
- Boehringer Ingelheim International
- Sever Pharma Solutions
- Pfizer Inc.
- Johnson & Johnson.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2023
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2023
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2023
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2023
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2023
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)